PD11-07 INTEGRATED RESULTS OF TWO MULTICENTER, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND, PHASE 3 TRIALS (SPI-611/612) OF SINGLE-DOSE INTRAVESICAL APAZIQUONE IMMEDIATELY FOLLOWING RESECTION IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

Authors :: Mark S. Soloway
Lee F. Allen
Daniel Saltzstein
Neal D. Shore
Guru Reddy
Gajanan Bhat
Lawrence Karsh
Source :: Journal of Urology. 195
Publication Year :: 2016
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2016.

Subjects :: medicine.medical_specialty
Bladder cancer
business.industry
Urology
030232 urology & nephrology
medicine.disease
Placebo
Resection
Double blind
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
medicine
In patient
Apaziquone
Non muscle invasive
business

Tools